CGT breakups between big pharma and biotech, first glimpse into earnings season and more...
Do you think 5 bn annual revenue is likely for Carvykti? Seems ambitious.
Indeed ambitious, hard but not impossible 🙌🙌
May actually depend on how FDA positions CART safety/efficacy tradeoff in earlier lines
Do you think 5 bn annual revenue is likely for Carvykti? Seems ambitious.
Indeed ambitious, hard but not impossible 🙌🙌
May actually depend on how FDA positions CART safety/efficacy tradeoff in earlier lines